ATE223405T1 - Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure - Google Patents

Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure

Info

Publication number
ATE223405T1
ATE223405T1 AT97927006T AT97927006T ATE223405T1 AT E223405 T1 ATE223405 T1 AT E223405T1 AT 97927006 T AT97927006 T AT 97927006T AT 97927006 T AT97927006 T AT 97927006T AT E223405 T1 ATE223405 T1 AT E223405T1
Authority
AT
Austria
Prior art keywords
methylthien
enyl
hydrochloride
modified form
nipecotic acid
Prior art date
Application number
AT97927006T
Other languages
English (en)
Inventor
Preben Ahrndt
Henning Borge Petersen
Vincent H Chang
Kimberly Ann Allen
Michael H Chain
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE223405T1 publication Critical patent/ATE223405T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT97927006T 1996-06-14 1997-06-03 Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure ATE223405T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK66196 1996-06-14
PCT/DK1997/000244 WO1997047619A1 (en) 1996-06-14 1997-06-03 Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride

Publications (1)

Publication Number Publication Date
ATE223405T1 true ATE223405T1 (de) 2002-09-15

Family

ID=8096101

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927006T ATE223405T1 (de) 1996-06-14 1997-06-03 Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure

Country Status (20)

Country Link
EP (1) EP0906309B1 (de)
JP (1) JP2000511909A (de)
CN (1) CN1636565A (de)
AR (1) AR008236A1 (de)
AT (1) ATE223405T1 (de)
AU (1) AU723267B2 (de)
BR (1) BR9709725A (de)
CZ (1) CZ295578B6 (de)
DE (1) DE69715196T2 (de)
DK (1) DK0906309T3 (de)
ES (1) ES2181002T3 (de)
HU (1) HUP9904035A3 (de)
IL (1) IL127469A (de)
NO (1) NO316889B1 (de)
PL (1) PL190858B1 (de)
PT (1) PT906309E (de)
RU (1) RU2177478C2 (de)
UA (1) UA52661C2 (de)
WO (1) WO1997047619A1 (de)
ZA (1) ZA975266B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5914333A (en) * 1996-07-31 1999-06-22 Novo Nordisk A/S Treatment of psychotic disorders
EP0991409B1 (de) * 1997-08-01 2002-01-30 ELAN CORPORATION, Plc Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
IE970588A1 (en) 1997-08-01 2000-08-23 Elan Corp Plc Controlled release pharmaceutical compositions containing tiagabine
CN1314684C (zh) * 2003-12-24 2007-05-09 中国科学院上海有机化学研究所 噻加宾及其消旋体和s-构型的合成方法及其无定形粉末的制法
GB0402118D0 (en) * 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
WO2005092886A1 (en) * 2004-03-29 2005-10-06 Ranbaxy Laboratories Limited Process for the preparation of amorphous form of tiagabine
US20080064727A1 (en) * 2006-08-18 2008-03-13 Cephalon, Inc. Crystalline forms of tiagabine hydrochloride

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK288385D0 (da) * 1985-06-26 1985-06-26 Novo Industri As Aminosyrederivater
DK58291D0 (da) * 1991-04-02 1991-04-02 Novo Nordisk As Krystalinsk stof og dets fremstilling

Also Published As

Publication number Publication date
IL127469A (en) 2001-01-11
EP0906309A1 (de) 1999-04-07
JP2000511909A (ja) 2000-09-12
CZ401998A3 (cs) 1999-06-16
DE69715196T2 (de) 2003-05-15
ES2181002T3 (es) 2003-02-16
NO985809L (no) 1998-12-11
RU2177478C2 (ru) 2001-12-27
AR008236A1 (es) 1999-12-29
AU723267B2 (en) 2000-08-24
DK0906309T3 (da) 2002-12-16
HUP9904035A3 (en) 2000-07-28
UA52661C2 (uk) 2003-01-15
EP0906309B1 (de) 2002-09-04
NO316889B1 (no) 2004-06-14
PT906309E (pt) 2002-12-31
CZ295578B6 (cs) 2005-08-17
AU3165397A (en) 1998-01-07
WO1997047619A1 (en) 1997-12-18
PL190858B1 (pl) 2006-02-28
PL330424A1 (en) 1999-05-10
HUP9904035A2 (hu) 2000-05-28
NO985809D0 (no) 1998-12-11
DE69715196D1 (de) 2002-10-10
CN1636565A (zh) 2005-07-13
IL127469A0 (en) 1999-10-28
BR9709725A (pt) 1999-08-10
ZA975266B (en) 1998-02-04

Similar Documents

Publication Publication Date Title
PT925298E (pt) Derivados 6,6-hetero-biciclicos substituidos
ID29241A (id) Turunan-turunan kinolin teranelasi-1,2
PT1000048E (pt) Derivados substituidos do 1,2,3,4-tetrahidronaftaleno
ATE340176T1 (de) Substituierte 6,5-heterobicyclische-derivate
DE69718771D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalinderivate
FI954255A0 (fi) 2,9-diamino- ja 2-amino-8-karbaomyyli-4-hydroksi-alkaanihappoamidijohdannaiset
DE69938258D1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
DE60143651D1 (de) Regelung des querprofils bei der bahnherstellung
DK1254118T3 (da) Substituerede 1,2,3,4-tetrahudroquinolin-2-carboxylsyrederivater
PT882726E (pt) Carbazol-carboxamidas como agonistas 5-ht1f
NO20003825L (no) 1,3,4 - oxadiazolonderivater
ATE223405T1 (de) Modifizierte form des hydrochlorids der r(-)-n-(4,4-di(-3-methylthien-2-yl)but-3-enyl)- nipecotinsäure
NO20030868D0 (no) N-(3,5-diklor-2-metoksyfenyl)-4-metoksy-3-piperazin-1-yl- benzensulfonamid
ATE234839T1 (de) 4,5-azolo-oxindole
ID26573A (id) Bentuk ke-vi dari 5, 6-dikloro-2-(isopropilamino) 1-(b-l-ribofurasonil)-1h-benzimidazol
DE69908923D1 (de) 1,3,4-thiadiazolylazofarbstoffe-enthaltende tintenzusammensetzungen
NO20005856L (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
CA2257931A1 (en) Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
DE69815690D1 (de) Herstellung von alkylierten aromatischen Aminen
ITBO980267A0 (it) Marca identificativa, in particolare per l'identificazione di bestiame
DK1274687T3 (da) 1,2,3,4-tetrahydroisoquinolinderivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0906309

Country of ref document: EP